- The clinical outcomes of second-line chemotherapy in patients with advanced pancreatic cancer: a retrospective study
-
Jung Hy, Lee EM
- KMID: 2529270
- J Yeungnam Med Sci.
- 2022 Apr;39(2):124-132.
- doi: 10.12701/yujm.2021.01347
Background: Despite recent advances in first-line chemotherapy for advanced pancreatic cancer, standard treatment after the failure of initial chemotherapy has not been established. Hence, we aimed to retrospectively analyze the... -
- CITED
-
- Close
- SHARE
-
- Close
- Mutations of p53 associated with pancreatic cancer and therapeutic implications
-
Voutsadakis IA
- KMID: 2519287
- Ann Hepatobiliary Pancreat Surg.
- 2021 Aug;25(3):315-327.
- doi: 10.14701/ahbps.2021.25.3.315
Pancreatic adenocarcinoma is a malignancy with rising incidence and grim prognosis. Despite improvements in therapeutics for treating metastatic pancreatic cancer, this disease is invariably fatal with survival time less than... -
- CITED
-
- Close
- SHARE
-
- Close
- Gemcitabine and Erlotinib with or without Oxaliplatin in Previously Untreated Advanced Pancreatic Cancer: A Randomized Phase II Trial
-
Lim SH, Yun J, Lee MY, Kim HJ, Kim KH, Kim SH, Lee SC, Bae SB, Kim CK, Lee N, Lee KT, Park SK, Lee YN, Moon JH
- KMID: 2518564
- Yonsei Med J.
- 2021 Aug;62(8):671-678.
- doi: 10.3349/ymj.2021.62.8.671
Purpose: Erlotinib has been the only targeted agent to show significantly improved outcomes in pancreatic adenocarcinoma when combined with gemcitabine. We aimed to evaluate whether the addition of oxaliplatin to... -
- CITED
-
- Close
- SHARE
-
- Close
- Impact of diabetes mellitus on morbidity and survival after pancreaticoduodenectomy for malignancy
-
Deo KB, Kulkarni AA, Kumar-M P, Krishnamurthy G, Shenvi S, Rana SS, Kapoor R, Gupta R
- KMID: 2516244
- Ann Hepatobiliary Pancreat Surg.
- 2021 May;25(2):230-241.
- doi: 10.14701/ahbps.2021.25.2.230
Backgrounds/Aims: Diabetes mellitus (DM) is a known risk factor for morbidity, length of hospital stay, or mortality after surgery, however, its impact on postoperative course and long-term survival after pancreaticoduodenectomy... -
- CITED
-
- Close
- SHARE
-
- Close
- Updates of Chemotherapy and Radiotherapy for Pancreatic Cancer
-
Sung MJ, Bang S
- KMID: 2504997
- Korean J Pancreas Biliary Tract.
- 2020 Jul;25(2):72-82.
- doi: 10.15279/kpba.2020.25.2.72
Pancreatic cancer is still one of the most aggressive malignancy, showing 10% of 5-year survival. Among the several reasons of the grave prognosis, the poor response to chemotherapeutic agents and... -
- CITED
-
- Close
- SHARE
-
- Close
- Percutaneous Radiofrequency Ablation for Metachronous Hepatic Metastases after Curative Resection of Pancreatic Adenocarcinoma
-
Lee SJ, Kim JH, Kim SY, Won HJ, Shin YM, Kim PN
- KMID: 2470755
- Korean J Radiol.
- 2020 Mar;21(3):316-324.
- doi: 10.3348/kjr.2019.0647
OBJECTIVE: To retrospectively evaluate the safety and efficacy of percutaneous radiofrequency ablation (RFA) in patients with metachronous hepatic metastases arising from pancreatic adenocarcinoma who had previously received curative surgery. MATERIALS AND... -
- CITED
-
- Close
- SHARE
-
- Close
- Prognostic value of COL6A3 in pancreatic adenocarcinoma
-
Svoronos C, Tsoulfas G, Souvatzi M, Chatzitheoklitos E
- KMID: 2471189
- Ann Hepatobiliary Pancreat Surg.
- 2020 Feb;24(1):52-56.
- doi: 10.14701/ahbps.2020.24.1.52
BACKGROUNDS/AIMS: Pancreatic cancer is one of the most fatal human malignancies with poor prognosis, despite advances in therapy. Here, we evaluated the potential role of collagen type VI α3 chain... -
- CITED
-
- Close
- SHARE
-
- Close
- Impact of BRCA1/2 gene mutations on survival of patients with pancreatic cancer: A case-series analysis
-
Navarro EB, López EV, Quijano Y, Caruso R, Ferri V, Durand H, Cabrera IF, Reques ED, Ielpo B, Glagolieva AY, Plaza C
- KMID: 2448778
- Ann Hepatobiliary Pancreat Surg.
- 2019 May;23(2):200-205.
- doi: 10.14701/ahbps.2019.23.2.200
BRCA gene mutations are found in up to 10% of pancreatic adenocarcinoma cases. We present a description of 4 cases along with a review of the current literature regarding pathogenesis,... -
- CITED
-
- Close
- SHARE
-
- Close
- Contemporary management of borderline resectable pancreatic ductal adenocarcinoma
-
Lekka K, Tzitzi E, Giakoustidis A, Papadopoulos V, Giakoustidis D
- KMID: 2448761
- Ann Hepatobiliary Pancreat Surg.
- 2019 May;23(2):97-108.
- doi: 10.14701/ahbps.2019.23.2.97
Pancreatic ductal adenocarcinoma (PDAC) remains one of the most aggressive tumors, with a low rate of survival, likely due to the tendency of the tumor for early local and distant... -
- CITED
-
- Close
- SHARE
-
- Close
- Inflammation and Cancer Development in Pancreatic and Biliary Tract Cancer
-
Lee SH, Park SW
- KMID: 2373366
- Korean J Gastroenterol.
- 2015 Dec;66(6):325-339.
- doi: 10.4166/kjg.2015.66.6.325
Chronic inflammation has been known to be a risk for many kinds of cancers, including pancreatic and biliary tract cancer. Recently, inflammatory process has emerged as a key mediator of... -
- CITED
-
- Close
- SHARE
-
- Close
- A Case of Agenesis of the Dorsal Pancreas with Concomitant Pancreatic Ductal Adenocarcinoma in an Adult Patient
-
Park JE, Jung SY, Lee JY, Lee EH, Goag EK, Lee SH, Cha BH
- KMID: 2448479
- Korean J Pancreas Biliary Tract.
- 2015 Apr;20(2):83-87.
- doi: 10.15279/kpba.2015.20.2.83
Agenesis of dorsal pancreas (ADP) is an extremely rare congenital anomaly defined as an absence of the dorsal ductal system resulting from failure in the embryologic development of the pancreatic... -
- CITED
-
- Close
- SHARE
-
- Close
- RE: Atypical Pulmonary Metastases from Pancreatic Adenocarcinoma
-
Virgilio E, Iannicelli E, Balducci G
- KMID: 2078652
- Korean J Radiol.
- 2014 Jun;15(3):399-400.
- doi: 10.3348/kjr.2014.15.3.399
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Is a Preoperative Assessment of the Early Recurrence of Pancreatic Cancer Possible after Complete Surgical Resection?
-
La Torre M, Nigri G, lo Conte A, Mazzuca F, Tierno SM, Salaj A, Marchetti , Ziparo V, Ramacciato G
- KMID: 1774535
- Gut Liver.
- 2014 Jan;8(1):102-108.
BACKGROUND/AIMS: The prognosis of pancreatic adenocarcinoma (PAC) is poor. The serum carbohydrate antigen 19-9 (CA 19-9) level has been identified as a prognostic indicator of recurrence and reduced overall survival.... -
- CITED
-
- Close
- SHARE
-
- Close
- Transcatheter Arterial Chemoembolization for Hepatic Recurrence after Curative Resection of Pancreatic Adenocarcinoma
-
Kim JH, Choi EK, Yoon HK, Ko GY, Sung KB, Gwon DI
- KMID: 1974142
- Gut Liver.
- 2010 Sep;4(3):384-388.
BACKGROUND/AIMS: Despite curative resection, hepatic recurrences cause a significant reduction in survival in patients with primary pancreatic adenocarcinoma. Transcatheter arterial chemoembolization (TACE) has recently been used successfully to treat primary... -
- CITED
-
- Close
- SHARE
-
- Close
- Prognostic Factors and Survival Rate of Pancreatic Adenocarcinoma after Curative Surgery
-
Chang HJ, Lee JG, Kang CM, Kim KS, Choi JS, Kim BR, Lee WJ
- KMID: 2145103
- J Korean Surg Soc.
- 2005 Aug;69(2):152-156.
PURPOSE: This retrospective study aimed to identify the outcomes of resected pancreatic cancers and determine the prognostic factors for long term survival based on a single hospital experience. METHODS: Between... -
- CITED
-
- Close
- SHARE
-
- Close
- Biliary Tract and Pancreas: Survival and Recurrence Pattern after Curative Resection of Pancreatic Cancer
-
Whang YW, Jang HJ, Lee JK, Seo JH, Park YS, Lee JH, Lee SJ, Lee JP, Song SY, Chung JB, Kang JK
- KMID: 2304591
- Korean J Gastroenterol.
- 2001 Oct;38(4):276-283.
BACKGROUND/AIMS: The only hope for the cure of pancreatic adenocarcinoma is curative resection. However, the rate of recurrence after curative resection is higher than 50%. The aim, of this study... -
- CITED
-
- Close
- SHARE
-
- Close
- Significance of Tumor Angiogenesis and p53 Protein Expression in Pancreatic Adenocarcinoma
-
Kim SS, Kim MC, Hong SH
- KMID: 2209425
- J Korean Surg Soc.
- 2001 Jul;61(1):86-94.
PURPOSE: This study was designed to examine the microvessel count and p53 protein expression level in pancreatic adenocarcinoma patients and to determine how they correlate with the clinicopathologic factors and... -
- CITED
-
- Close
- SHARE
-
- Close
- Immunohistochemical Evaluation of Ki - 67 , p53 , K - ras Expression in Chronic Pancreatitis and Pancreatic Adenocarcinoma
-
Kim IH, Lee DH, Lee JW, Choi W, Kim PS, Kim HG, Kwon KS, Cho HG, Shin YW, Kim YS, Kim YB
- KMID: 2084984
- Korean J Gastroenterol.
- 2001 May;37(5):370-378.
BACKGROUND/AIMS: Hyperplasia or dysplasia of pancreatic duct epithelium has been frequently found in the pancreas of pancreatic cancer or chronic pancreatitis. We hypothesized that ductal hyperplasia and dysplasia in the... -
- CITED
-
- Close
- SHARE
-
- Close
- A Case of Umbilical Metastasis as the Presenting Sign of Pancreatic Adenocarcinoma
-
Chang WI, Han SW, Yoon JG, Lee DH, Sung YJ, Kim BW, Kim JI, Park SH, Oh SH, Song HJ, Choi KY, Sun HS
- KMID: 2084976
- Korean J Gastroenterol.
- 2001 Jan;37(1):60-63.
Metastatic cancer of the umbilicus is very rare and is called Sister Mary Joseph's nodule. The most common primary site of umbilical metastasis is an adenocarcinoma of the stomach and... -
- CITED
-
- Close
- SHARE
-
- Close
- Significance of K-ras mutation, K-ras expression and p53 expression in pancreatic cancer
-
Kim YC, Choi KH, Kim HG, Lee ES, Son GS
- KMID: 2244393
- Korean J Hepatobiliary Pancreat Surg.
- 2000 Feb;4(1):111-121.
BACKGROUND: Though K-ras mutation and aberrant p53 have been considered the event of the oncogenesis of pancreatic adenocarcinoma, it is controversial that these have been attributed to difference of survival... -
- CITED
-
- Close
- SHARE
-
- Close
